Research ArticleVasculitis
Risk Factors for Relapse of Antineutrophil Cytoplasmic Antibody-associated Vasculitis in Japan: A Nationwide, Prospective Cohort Study
Akinori Hara, Takashi Wada, Ken-ei Sada, Koichi Amano, Hiroaki Dobashi, Masayoshi Harigai, Yoshinari Takasaki, Hidehiro Yamada, Hitoshi Hasegawa, Taichi Hayashi, Shouichi Fujimoto, Eri Muso, Tamihiro Kawakami, Sakae Homma, Masaharu Yoshida, Junichi Hirahashi, Noriyoshi Ogawa, Satoshi Ito, Hirofumi Makino and Yoshihiro Arimura for the Research Committee on Intractable Vasculitides, and the Strategic Study Group to Establish the Evidence for Intractable Vasculitis Guideline
The Journal of Rheumatology April 2018, 45 (4) 521-528; DOI: https://doi.org/10.3899/jrheum.170508
Akinori Hara
From the Department of Environmental and Preventive Medicine, and Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama; Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama; Division of Endocrinology and Metabolism, Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa; Division of Rheumatology and Allergology, Departments of Internal Medicine and Dermatology, St. Marianna University School of Medicine, Kawasaki; Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Matsuyama; Department of Rheumatology, Faculty of Medicine, University of Tsukuba, Tsukuba; Department of Hemovascular Medicine and Artificial Organs, Faculty of Medicine, University of Miyazaki, Miyazaki; Center for Nephrology and Urology, Division of Nephrology and Dialysis, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka; Third Department of Internal Medicine, Division of Immunology and Rheumatology, Hamamatsu University School of Medicine, Hamamatsu; Division of Rheumatology, Niigata Rheumatic Center, Shibata; Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University; Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine; Department of Respiratory Medicine, Toho University Omori Medical Center; Division of Nephrology, Tokyo Medical University Hachioji Medical Center; Department of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo; Nephrology and Rheumatology, First Department of Internal Medicine, Kyorin University School of Medicine, Tokyo,
Japan.
Takashi Wada
Ken-ei Sada
Koichi Amano
Hiroaki Dobashi
Masayoshi Harigai
Yoshinari Takasaki
Hidehiro Yamada
Hitoshi Hasegawa
Taichi Hayashi
Shouichi Fujimoto
Eri Muso
Tamihiro Kawakami
Sakae Homma
Masaharu Yoshida
Junichi Hirahashi
Noriyoshi Ogawa
Satoshi Ito
Hirofumi Makino
REFERENCES
- 1.↵
- 2.↵
- Yates M,
- Watts RA,
- Bajema IM,
- Cid MC,
- Crestani B,
- Hauser T,
- et al.
- 3.↵
- Wada T,
- Hara A,
- Arimura Y,
- Sada KE,
- Makino H;
- Research Group of Intractable Vasculitis, Ministry of Health, Labor, and Welfare of Japan
- 4.↵
- Sada KE,
- Yamamura M,
- Harigai M,
- Fujii T,
- Dobashi H,
- Takasaki Y,
- et al;
- Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan
- 5.↵
- Sada KE,
- Yamamura M,
- Harigai M,
- Fujii T,
- Takasaki Y,
- Amano K,
- et al;
- Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan
- 6.↵
- Watts R,
- Lane S,
- Hanslik T,
- Hauser T,
- Hellmich B,
- Koldingsnes W,
- et al.
- 7.↵
- 8.↵
- 9.↵
- 10.↵
- Hellmich B,
- Flossmann O,
- Gross WL,
- Bacon P,
- Cohen-Tervaert JW,
- Guillevin L,
- et al.
- 11.↵International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Clinical safety data management: definitions and standards for expedited reporting E2A. [Internet. Accessed December 21, 2017.] Available from: www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2A/Step4/E2A_Guideline.pdf
- 12.↵
- 13.↵
- Furuta S,
- Chaudhry AN,
- Hamano Y,
- Fujimoto S,
- Nagafuchi H,
- Makino H,
- et al.
- 14.↵
- Lionaki S,
- Blyth ER,
- Hogan SL,
- Hu Y,
- Senior BA,
- Jennette CE,
- et al.
- 15.↵
- 16.↵
- 17.↵
- Iwabuchi M,
- Nakaya I,
- Tsuchiya Y,
- Shibagaki Y,
- Yamaguchi T,
- Fukuhara S,
- et al.
- 18.↵
- 19.↵
- 20.↵
- 21.↵
- 22.↵
- Hiemstra TF,
- Walsh M,
- Mahr A,
- Savage CO,
- de Groot K,
- Harper L,
- et al;
- European Vasculitis Study Group (EUVAS)
- 23.↵
- 24.↵
- 25.↵
- 26.↵
- 27.↵
- 28.↵
- Ball GV,
- Fessler BJ,
- Bridges SL Jr.
- Guillevin L,
- Terrier B
- 29.↵
- Puéchal X,
- Pagnoux C,
- Perrodeau É,
- Hamidou M,
- Boffa JJ,
- Kyndt X,
- et al;
- French Vasculitis Study Group
- 30.↵
- Kitagawa K,
- Furuichi K,
- Sagara A,
- Shinozaki Y,
- Kitajima S,
- Toyama T,
- et al;
- Kanazawa Study Group for Renal Diseases and Hypertension
In this issue
The Journal of Rheumatology
Vol. 45, Issue 4
1 Apr 2018
Risk Factors for Relapse of Antineutrophil Cytoplasmic Antibody-associated Vasculitis in Japan: A Nationwide, Prospective Cohort Study
Akinori Hara, Takashi Wada, Ken-ei Sada, Koichi Amano, Hiroaki Dobashi, Masayoshi Harigai, Yoshinari Takasaki, Hidehiro Yamada, Hitoshi Hasegawa, Taichi Hayashi, Shouichi Fujimoto, Eri Muso, Tamihiro Kawakami, Sakae Homma, Masaharu Yoshida, Junichi Hirahashi, Noriyoshi Ogawa, Satoshi Ito, Hirofumi Makino, Yoshihiro Arimura
The Journal of Rheumatology Apr 2018, 45 (4) 521-528; DOI: 10.3899/jrheum.170508
Risk Factors for Relapse of Antineutrophil Cytoplasmic Antibody-associated Vasculitis in Japan: A Nationwide, Prospective Cohort Study
Akinori Hara, Takashi Wada, Ken-ei Sada, Koichi Amano, Hiroaki Dobashi, Masayoshi Harigai, Yoshinari Takasaki, Hidehiro Yamada, Hitoshi Hasegawa, Taichi Hayashi, Shouichi Fujimoto, Eri Muso, Tamihiro Kawakami, Sakae Homma, Masaharu Yoshida, Junichi Hirahashi, Noriyoshi Ogawa, Satoshi Ito, Hirofumi Makino, Yoshihiro Arimura
The Journal of Rheumatology Apr 2018, 45 (4) 521-528; DOI: 10.3899/jrheum.170508